Do go read Jim's piece, here -- on the tripling of the number of lawsuits that allege blood clots resulted from use of the legacy Schering-Plough (nee Organon) NuvaRing® birth control drug/device:
. . . .The claims against NuvaRing are similar to those against the patch: Because the device delivers a constant stream of hormone unmediated by the digestive system or the liver, patients end up getting higher doses than they do from older pills. High estrogen doses create a greater risk of blood clots, which can be fatal. . . .
An earlier East Texas press report may be found here. We'll keep an eye on this, but as of now, it is barely material to New Merck's financial results. I guess the trend-line is troubling, though.
No comments:
Post a Comment